4//SEC Filing
Noiman Silvia 4
Accession 0001209191-18-040022
CIK 0001035354other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 4:12 PM ET
Size
7.8 KB
Accession
0001209191-18-040022
Insider Transaction Report
Form 4
Noiman Silvia
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2018-06-06$0.00/sh+349,400$210→ 490,789 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-06-06−349,400→ 0 totalExercise: $0.00Exp: 2024-04-26→ Common Stock (349,400 underlying)
Footnotes (3)
- [F1]The option was issued pursuant to the Company's Eloxx Pharmaceuticals Ltd. Share Ownership and Option Plan (2013) and was priced at Israeli New Shekel 0.0020. This amount reflects the U.S. dollar equivalent of the exercise price as of the transaction date using an exchange rate of 1:3.5736, as reported by Bloomberg.
- [F2]Represents the total number of shares owned by the Reporting Person as of the date of filing.
- [F3]The option was fully vested and exercisable as of October 26, 2016.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001340877
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 4:12 PM ET
- Size
- 7.8 KB